AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Total cash & short-term investments

Sumitomo Pharma Co., Ltd.【JP:4506】

Market cap
¥779.5B
P/E ratio
8.5x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndTotal cash & short-term investments (Million JPY)YoY (%)
Mar 31, 202539,956+10.58%
Mar 31, 202436,132-77.92%
Mar 31, 2023163,652-31.41%
Mar 31, 2022238,580+6.90%
Mar 31, 2021223,178+71.12%
Mar 31, 2020130,425-27.96%
Mar 31, 2019181,046+122.96%
Mar 31, 201881,201-23.11%
Mar 31, 2017105,603-22.33%
Mar 31, 2016135,961-4.15%
Mar 31, 2015141,846

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)